Buteyko Based Remedial Breathing Therapy With Children With Asthma

Not Applicable

Completed

• Conditions: Asthma

• Registration Number: NCT02140086
• Lead Sponsor: ARCIM Institute Academic Research in Complementary and Integrative Medicine

Brief Summary

A randomized, controlled trial to investigate the effects of a buteyko based remedial breathing therapy on children with asthma regarding to their symptoms, use of medication and lung function tests.

Detailed Description

Not available

Study Timeline

• Study Start: 2014-01
• Study First Submitted: 2014-05-14
• Study First Submitted QC: 2014-05-15
• Study First Posted: 2014-05-16
• Primary Completion: 2014-11
• Study Completion: 2014-11
• Status Verified: 2016-03
• Last Update Submitted: 2016-03-01
• Last Update Posted: 2016-03-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

• signed informed consent of the parents
• age 6- 15 years
• information and consent of the consulting doctor
• levels of asthma therapy 1-3

Exclusion Criteria

• participation in another study

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Primary Outcome Measures

Name	Time	Method
Reduction of Betamimetics (-30%) at 3- and/or 6-month follow up	asthmaspezific parameters are measured before and after intervention as well as 3- and 6- month follow up

Secondary Outcome Measures

Name	Time	Method
Paediatric asthma caregiver´s quality of life questionnaire (PACQLQ)	parameters are measured before and after intervention as well as 3- and 6- month follow up
NO-measurement nasal and oral	parameters are measured before and after intervention as well as 3- and 6- month follow up
parameters of spirometry	parameters are measured before and after intervention as well as 3- and 6- month follow up
Asthma Control Questionnaire (ACQ)	parameters are measured before and after intervention as well as 3- and 6- month follow up	Scores of the ACQ (Asthma Control Questionnaire)
Paediatric Asthma Quality of Life Questionnaire (PAQLQ)	parameters are measured before and after intervention as well as 3- and 6- month follow up	Scores of PAQLQ (Paediatric Asthma Quality of Life Questionnaire)
Buteyko-Questionnaire	parameters are measured before and after intervention as well as 3- and 6- month follow up
ARCIM Questionnaire (AFB)	parameters are measured before and after intervention as well as 3- and 6- month follow up	Scores of the AFB (ARCIM Questionnaire) regarding to asthma symptoms of the last 3 month (AFB is not validated)
Peak Flow	parameters are measured before and after intervention as well as 3- and 6- month follow up

Trial Locations

Locations (1)

Filderklinik; 🇩🇪 Filderstadt, Baden-Württemberg, Germany